The WACC of Biocartis Group NV (BCART.BR) is 7.3%.
| Range | Selected | |
| Cost of equity | 5.90% - 12.20% | 9.05% |
| Tax rate | 0.30% - 0.30% | 0.30% |
| Cost of debt | 6.90% - 7.00% | 6.95% |
| WACC | 6.7% - 7.9% | 7.3% |
| Category | Low | High |
| Long-term bond rate | 2.9% | 3.4% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.51 | 1.19 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.90% | 12.20% |
| Tax rate | 0.30% | 0.30% |
| Debt/Equity ratio | 4.49 | 4.49 |
| Cost of debt | 6.90% | 7.00% |
| After-tax WACC | 6.7% | 7.9% |
| Selected WACC | 7.3% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for BCART.BR:
cost_of_equity (9.05%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (0.51) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.